Procurement of enzyme replacement therapy beta-agalsidase and alpha-alglucosidase AI

TEDAS your procurement assistant

Ask a question about this procurement

t

Procurement object

  • Products to be procured: Enzyme replacement therapy drugs: beta-agalsidase (powder for concentrate for solution for infusion 35mg and 5mg) and alpha-alglucosidase (powder for concentrate for solution for infusion 50mg).
  • Technical requirements: The drugs must comply with the technical specifications. At the time of delivery, the drug must have at least 75% of its shelf life remaining.
  • Location: Paldiski mnt 68, Tallinn (Lääne-Tallinn Central Hospital pharmacy).

Contract terms

*…
 
To see full summary, please log in or register.

t

👋 Hello! I am TEDAS – your procurement assistant 💼✨

What would you like to know about this procurement?

Note: This is preliminary information. For accuracy, please review all procurement documents.
Ask your questions here...

311522_ESPD_v2.0_laiendatud.xml

311522_hankepass_taiendavate_selgitustega.pdf

311522_hindamiskriteeriumid.pdf

311522_vastavustingimused.pdf

311522.zip

Alusdokumendid.docx

Lisa 1 - Lepingu projekt.docx

Vorm 1 - Tehniline kirjeldus.xlsx

Ready to get started?

Subscribe and enjoy all the benefits every day!